维普中文期刊产品整合服务
42篇 您的检索式:作者名="Marc Fisher"
    题名 作者 年代 出处 被引量
1卒中和短暂性脑缺血发作患者的卒中预防指南美国心脏协会/美国卒中协会为医疗卫生专业人员制定的指南显示文摘本更新版指南旨在为缺血性卒中或短暂性脑缺血发作存活者的卒中预防提供全面和及时的循证推荐.本指南适用于所有为上述患者提供二级预防的临床医生.这些循证推荐包括危险因素的控制、血管闭塞的干预、心源性栓塞的抗栓治疗以及非心源性栓塞性卒中的抗血小板治疗.还对各种特殊情况下复发性卒中的预防提供了推荐意见,包括主动脉弓粥样硬化、动脉夹层分离、卵圆孔未闭、高同型半胱氨酸血症、高凝状态、抗心磷脂抗体综合征、镰状细胞病、脑静脉窦血栓形成以及妊娠.此外,还有专门的章节对颅内出血后抗栓和抗凝治疗的应用以及指南的实施进行了讨论.Walter N.Kernan Bruce Ovbiagele Henry R.Black Dawn M.Bravata Marc I.Chimowitz Michael D.Ezekowitz Margaret C.Fang Marc Fisher Karen L.Furie 洪道俊 黄招君 李小兵 周美鸿 吴成斯 王博 卢艺 吴裕臣 2014国际脑血管病杂志2014,22,11:585
2卒中治疗专业学术圆桌会议临床前推荐更新版显示文摘首份卒中治疗专业学术圆桌会议(Stroke Yherapy Academic Industry Roundtable,STAIR)推荐于1999年出版,旨在提高潜在的急性卒中治疗方法的临床前研究质量。虽然这些推荐意见被认为是合理的,但并未得到严格的遵循和验证。为了更好地向临床转化,有关候选急性卒中疗法的临床前试验的质量和广度已取得实质性进展。更新后的STAIR临床前推荐进一步强调了最初提出的建议,即通过适当的生理学监测在多种动物物种中采用组织学和功能结局来确定可重复的剂量反应和时间窗。更新后的STAIR推荐意见包括:高质量科学研究的基本原则应消除随机和评价偏倚,预先确定纳入和排除标准,计算合适的效能和样本量,并公开潜在的利益冲突。应在年轻的健康雄性动物中进行初步评价之后,在雌性、高龄动物和伴有合并症(如高血压、糖尿病和高胆固醇血症)的动物中做进一步研究。此外还要在动物实验中应用临床相关生物学标志物。尽管只有通过临床试验产生基于此的有效疗法之后才能证实该推荐意见的有效性,但遵循这些推荐有望提高成功的机会。Marc Fisher Giora Feuerstein David W. Howells Patricia D. Hum Thomas A. Kent Sean I. Savitz Eng H. Lo 吕志宿(译) 罗本燕(译) 2009国际脑血管病杂志2009,17,8:5
3Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation显示文摘R. Todd Stravitz Mitchell L. Shiffman Melissa Kimmel Puneet Puri Velimir A. Luketic Richard K. Sterling Arun J. Sanyal Adrian H. Cotterell Marc P. Posner Robert A. Fisher 2012Liver Int2012,,7:3
4Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves Outcome显示文摘Richard Todd Stravitz Douglas M. Heuman Nisha Chand Richard K. Sterling Mitchell L. Shiffman Velimir A. Luketic Arun J. Sanyal Adil Habib Anastasios A. Mihas Ho-Chong S. Giles Daniel G. Maluf Adrian H. Cotterell Marc P. Posner Robert A. Fisher 2008The American Journal of Medicine2008,,2:3
5Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-Ⅱ (TRACE Ⅱ): rationale and design显示文摘Background and purpose Tenecteplase(TNK)is a promising agent for treatment of acute ischaemic stroke(AIS).We hypothesised that recombinant human TNK tissue-type plasminogen activator(rhTNK-tPA)is non-inferior to rt-PA in achieving excellent functional outcome at 90 days,when administered within 4.5 hours of ischaemic stroke onset.Methods and design Tenecteplase Reperfusion therapy in Acute ischemic Cerebrovascular Events(TRACE)is a phase Ⅲ,multicentre,prospective,randomised,open-label,blinded-end point non-inferiority study.Patients eligible for intravenous thrombolysis therapy are randomised to rhTNK-tPA 0.25 mg/kg(single bolus)to a maximum of 25 mg or rt-PA 0.9 mg/kg(10%bolus+90%infusion/1 hour)to a maximum of 90 mg.Medications considered necessary for the patient’s health may be given at the discretion of the investigator during 90-day follow-up.Study outcomes The primary study outcome is excellent functional outcome defined as modified Rankin Scale(mRS)0–1 at 90 days.Secondary efficacy outcomes include favourable functional outcome defined as mRS≤2 at 90 days,ordinal distribution of mRS and major neurological improvement on the National Institutes of Health Stroke Scale.Safety outcomes are symptomatic intracranial haemorrhage within 36 hours and death from any cause.Discussion There is no completed registration study of TNK in AIS worldwide.TRACE Ⅱ strives to provide evidence for a new drug application for rhTNK-tPA in AIS within 4.5 hours through a well-designed and rigorously executed randomised trial in China.Shuya Li Bruce C V Campbell Lee H Schwamm Marc Fisher Mark Parsons Hao Li Yuesong Pan Yongjun Wang 2022Stroke & Vascular Neurology2022,7,1:2
6Stroke显示文摘Geoffrey A Donnan Marc Fisher Malcolm Macleod Stephen M Davis 2008The Lancet . 2008 (9624)2008,,9624:2
7Stroke显示文摘Geoffrey A Donnan Marc Fisher Malcolm Macleod Stephen M Davis 2008The Lancet2008,,9624:2
8Single Pediatric Kidney Transplantation in Adult Recipients: Comparable Outcomes With Standard-Criteria Deceased-Donor Kidney Transplantation显示文摘Amit Sharma Rajesh Ramanathan Martha Behnke Robert Fisher Marc Posner 2013Transplantation Journal2013,,11:2
9Truth lies below: A case report and literature review of typical appearing polyps yet with an atypical diagnosis显示文摘BACKGROUND Enteropathy associated T-cell lymphoma(EATL) is a rare form of peripheral Tcell lymphoma and makes up less than 5% of gastrointestinal lymphomas. EATL can be divided into type 1 which is associated with celiac disease, and monomorphic epitheliotropic intestinal T-cell lymphoma(MEITL), formally type 2, which is not associated with celiac disease.CASE SUMMARY We present a 60-year-old African American female, without celiac disease, who presented with abdominal pain, diarrhea, and 30 lb. weight loss over a 3 month period. She was subsequently diagnosed with EATL throughout her entire gastrointestinal tract. She is currently undergoing chemotherapy with EOCH(Etoposide, Oncovin, Cyclophosphamide, and Hydroxydaunorubicin). EATL is most common in the Asian and Hispanic population yet the incidence in African Americans is uncertain and emphasizes the rarity of this case. A literature review was included to further emphasize similarities and differences between our case and previously reported cases of MEITL.CONCLUSION The patient was diagnosed with EATL, immunochemical testing was not conclusive for MEITL however was suggestive of the disease.Aaron Fisher Edward Yousif Marc Piper 2019World Journal of Gastrointestinal Endoscopy2019,11,1:2
10Stroke 显示文摘Geoffrey A Donnan Marc Fisher Malcolm Macleod 2008Lancet2008,371,9624:1
11Further evolution toward effective therapy for acute ischemic stroke显示文摘Marc Fisher Julien Bogousslavsky 1998JAMA1998,279,:1
12Surgical Management of Anatomical Variations of the Right Lobe in Living Donor Liver Transplantation显示文摘Amadeo Marcos John M. Ham Robert A. Fisher Ann T. Olzinski Marc P. Posner 2000Annals of Surgery2000,,6:1
13LIVER REGENERATION AND FUNCTION IN DONOR AND RECIPIENT AFTER RIGHT LOBE ADULT TO ADULT LIVING DONOR LIVER TRANSPLANTATION12显示文摘Amadeo Marcos Robert A. Fisher John M. Ham Mitchell L. Shiffman Arun J. Sanyal Velimir A. C. Luketic Richard K. Sterling Ann S. Fulcher Marc P. Posner 2000Transplantation2000,,7:1
14Comprehensive Control of Human Papillomavirus Infections and Related Diseases显示文摘F. Xavier Bosch Thomas R. Broker David Forman Anna-Barbara Moscicki Maura L. Gillison John Doorbar Peter L. Stern Margaret Stanley Marc Arbyn Mario Poljak Jack Cuzick Philip E. Castle John T. Schiller Lauri E. Markowitz William A. Fisher Karen Canfell Lyn 2013Vaccine2013,,:1
15Dawning of a New Era for Acute Stroke Therapy显示文摘Marc Fisher Ajay Wakhloo 2015Stroke2015,,:1
16Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves Outcome显示文摘Richard Todd Stravitz Douglas M. Heuman Nisha Chand Richard K. Sterling Mitchell L. Shiffman Velimir A. Luketic Arun J. Sanyal Adil Habib Anastasios A. Mihas Ho-Chong S. Giles Daniel G. Maluf Adrian H. Cotterell Marc P. Posner Robert A. Fisher 2008The American Journal of Medicine2008,,2:1
17En Bloc Kidney Transplantation From Pediatric Donors: Comparable Outcomes With Living Donor Kidney Transplantation显示文摘Amit Sharma Robert A. Fisher Adrian H. Cotterell Anne L. King Daniel G. Maluf Marc P. Posner 2011Transplantation2011,,5:1
18Further evolution toward effective therapy for acute ischemic stroke显示文摘Marc Fisher 1998J AMA1998,279,:1
19Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat显示文摘Nils Henninger Kenneth M. Sicard Zhixin Li Praveen Kulkarni Stephan Dützmann Christian Urbanek Stefan Schwab Marc Fisher 2007Critical Care Medicine2007,,11:1
20Further Evolution Toward Effective Therapy for Acute Ischemic Stroke显示文摘 Julien Bogousslavsky 1998JAMA1998,279,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费